Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Chemical synthesis and biological evaluation of a NAD(P)H:quinone oxidoreductase-1-targeted tripartite quinone drug delivery system

Autor: Volpato, Milène, Abou-Zeid, N., Tanner, R.W., Glassbrook, L.T., Taylor, James P., Stratford, I.J., Loadman, Paul, Jaffar, M., Phillips, Roger M.

NAD(P)H:quinone oxidoreductase-1 (NQO1) is a potential target for therapeutic intervention but attempts to exploit NQO1 using quinone-based bioreductive prodrugs have been largely compromised by toxicity to organs that inherently express high levels

Externí odkaz: http://hdl.handle.net/10454/4567

EFFICACY OF ANTAGONISTIC FUNGAL AND BACTERIAL BIOAGENTS AGAINST FABA BEAN DAMPING-OFF DISEASE.

Autor: Mahmoud, Noher A., Khalifa, Neamat A., Abbas, M. S., Sobhy, H. M., Abou- Zeid, N. M.

Publikováno v: Zagazig Journal of Agricultural Research; 2018, Vol. 45 Issue 3, p917-929, 13p

Population dynamics of the leopard moth, Zeuzera pyrina L., and its control on olive trees in Egypt / Populationsdynamik des Blausiebs, Zeuzera pyrina L., und seine Bekämpfung an Olivenbäumen in Ägypten

Autor: Ismail, I. I., Abou-Zeid, N. A., Abdallah, F. F.

Publikováno v: Zeitschrift für Pflanzenkrankheiten und Pflanzenschutz / Journal of Plant Diseases and Protection, 1992 Oct 01. 99(5), 519-524.

Externí odkaz: https://www.jstor.org/stable/43386098

Towards a cancer mission in Horizon Europe: recommendations.

Autor: Berns A; The Netherlands Cancer Institute, Amsterdam, the Netherlands.; European Academy of Cancer Sciences, Stockholm, Sweden., Ringborg U; European Academy of Cancer Sciences, Stockholm, Sweden.; Cancer Center Karolinska, Karolinska University Hospital, Stockholm, Sweden., Celis JE; European Academy of Cancer Sciences, Stockholm, Sweden.; Danish Cancer Society Research Centre, Copenhagen, Denmark., Heitor M; Ministry for Science, Technology and Higher Education, Lisbon, Portugal., Aaronson NK; The Netherlands Cancer Institute, Amsterdam, the Netherlands., Abou-Zeid N; Fondation ARC pour la recherché sur le cancer, Villejuif, France., Adami HO; Karolinska Institutet, Stockholm, Sweden., Apostolidis K; European Cancer Patient Coalition, Brussels, Belgium., Baumann M; European Academy of Cancer Sciences, Stockholm, Sweden.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Bardelli A; The European Association for Cancer Research, Nottingham, UK.; Department of Oncology, University of Torino, Candiolo (TO), Italy., Bernards R; The Netherlands Cancer Institute, Amsterdam, the Netherlands.; The European Association for Cancer Research, Nottingham, UK., Brandberg Y; Karolinska Institutet, Stockholm, Sweden., Caldas C; European Academy of Cancer Sciences, Stockholm, Sweden.; Cancer Research UK Cambridge Centre, Cambridge, UK., Calvo F; Gustave Roussy Cancer Campus Grand Paris, Villejuif, France., Dive C; The European Association for Cancer Research, Nottingham, UK.; Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK., Eggert A; Charite-Universitatsmedizin, Berlin, Germany., Eggermont A; European Academy of Cancer Sciences, Stockholm, Sweden.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Espina C; International Agency for Research on Cancer (IARC/WHO), Lyon, France.; Cancer Prevention Europe, Lyon, France., Falkenburg F; Dutch Cancer Society, Amsterdam, the Netherlands., Foucaud J; French National Cancer Institute (INCa), Boulogne Billancourt, France., Hanahan D; Swiss Institute for Experimental Cancer Research (ISREC), Federal Institute of Technology in Lausanne (EPFL), Lausanne, Switzerland.; Swiss Cancer Center Leman (SCCL), Lausanne, Switzerland., Helbig U; German Cancer Aid, Bonn, Germany., Jönsson B; Stockholm School of Economics, Stockholm, Sweden., Kalager M; Institute of Health and Society, University of Oslo, Oslo, Norway., Karjalainen S; Association of European Cancer Leagues (ECL), Brussels, Belgium., Kásler M; Ministry of Human Resources, Budapest, Hungary., Kearns P; SIOPE Head Office, Brussels, Belgium.; NIHR Birmingham Biomedical Research Centre, University of Birmingham, Birmingham, UK., Kärre K; The Swedish Cancer Society, Stockholm, Sweden., Lacombe D; EORTC Headquarters, Brussels, Belgium., de Lorenzo F; European Cancer Patient Coalition, Brussels, Belgium., Meunier F; Federation of European Academies of Medicine, Brussels, Belgium., Nettekoven G; German Cancer Aid, Bonn, Germany., Oberst S; Cancer Research UK Cambridge Centre, Cambridge, UK.; Organisation of European Cancer Institutes (OECI), Brussels, Belgium., Nagy P; Organisation of European Cancer Institutes (OECI), Brussels, Belgium.; National Institute of Oncology, Budapest, Hungary., Philip T; Organisation of European Cancer Institutes (OECI), Brussels, Belgium.; Institut Curie, Paris, France., Price R; The European Cancer Organisation (ECCO), Brussels, Belgium., Schüz J; International Agency for Research on Cancer (IARC/WHO), Lyon, France.; Cancer Prevention Europe, Lyon, France., Solary E; Fondation ARC pour la recherché sur le cancer, Villejuif, France.; Gustave Roussy Cancer Campus Grand Paris, Villejuif, France., Strang P; Karolinska Institutet, Stockholm, Sweden., Tabernero J; Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain., Voest E; The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Cancer Core Europe, Amsterdam, the Netherlands.

Publikováno v: Molecular oncology [Mol Oncol] 2020 Aug; Vol. 14 (8), pp. 1589-1615.